trial · primary record
Linperlisib
Acquired Pure Red Cell Aplasia
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | Not stated |
| Primary completion | 2026-10-30 |
| Primary endpoint | Overall response rate(ORR) |
| Registry ID | NCT07031115 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:33.635Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07031115
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.